S100A9 and pancreatic neoplasm: A previous proteomics analysis reported that S100A9 protein was detected in 44% of urine samples, but not in plasma, of pancreatic cancer patients 6, which indicates that urine proteomics might provide tumor-specific biomarkers for pancreatic cancer.